Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseTissue DonorsTransplantation ConditioningHematologic NeoplasmsHistocompatibility TestingBone MarrowHematopoietic Stem Cell MobilizationBone Marrow CellsHistocompatibilityGranulocyte Colony-Stimulating FactorLeukapheresisHematopoietic Stem CellsStem Cell TransplantationBlood Component RemovalStem CellsTreatment OutcomeGraft SurvivalTissue and Organ ProcurementImmunosuppressive AgentsHLA AntigensLeukemiaCord Blood Stem Cell TransplantationMelphalanMultiple MyelomaCombined Modality TherapyCyclophosphamideWhole-Body IrradiationBusulfanRecurrenceBlood DonorsAntineoplastic Combined Chemotherapy ProtocolsTransplantation ChimeraRetrospective StudiesLymphoma, Non-HodgkinBone and BonesAnemia, AplasticTime FactorsBlood CellsHematopoiesisKidney TransplantationMyeloablative AgonistsBone Marrow PurgingBone Marrow DiseasesBlood Cell CountLiver TransplantationSurvival RateRemission InductionCytomegalovirus InfectionsSurvival AnalysisTransplantationLeukocyte TransfusionEtoposideLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteDisease-Free SurvivalLymphomaOpportunistic InfectionsRegistriesImmunocompromised HostAntineoplastic Agents, AlkylatingThiotepaHematologic DiseasesLiving DonorsFlow CytometryAcute DiseaseVidarabineNeoplasmsSalvage TherapyImmunosuppressionMyelodysplastic SyndromesTransplantation, IsogeneicInfectionT-LymphocytesGraft RejectionHodgkin DiseaseCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaCell SeparationTransplantation ImmunologyFollow-Up StudiesCells, CulturedPlatelet CountLymphocyte DepletionImmunophenotypingColony-Forming Units AssayNeutropeniaCyclosporineCytarabineHeart TransplantationFatal OutcomeLeukocyte CountProspective StudiesAntineoplastic AgentsLeukemia, MyeloidRecombinant Proteins